Reversal Effect of Sertraline on Multidrug Resistance of Staphylococcus aureus

被引:0
|
作者
Meng H. [1 ]
Xie S. [1 ]
Li L. [2 ]
Chen M. [3 ]
机构
[1] School of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, Guangdong
[2] Food Safety and Nutrition Research Institute, Jinan University, Guangzhou, 510632, Guangdong
[3] Xiamen Hongyi Testing Co., Ltd., Xiamen, 361100, Fujian
关键词
Efflux pump; Multi-drug resistance; SCCmec gene cassette; Sertraline;
D O I
10.12141/j.issn.1000-565X.190097
中图分类号
学科分类号
摘要
Multidrug-resistant Staphylococcus aureus (S. aureus) were taken as object to investigate the reversal effect of sertraline on multi-drug resistance of S. aureus and its reversal mechanism through the determination of minimum inhibitory concentration, growth rate, time-kill curves under the combination of non-antibiotics sertraline and different antibiotics, as well as transcriptional level of the drug resistance gene mecA and the efflux pump gene norA by real-time PCR. The results indicate that when the sertraline concentration is higher than 1μg/mL, the growths of S. aureus are inhibited; when sertraline (1/2 MIC) is combined with tetracycline, it has a bactericidal effect on S. aureus. Sertraline combined with tetracycline, ciprofloxacin, and clindamycin, it has synergistic or additive inhibitory effect on S. aureus, which could increase the sensitivity of three antibiotics by more than 75%. Low concentration of sertraline could significantly reduce the expression of the efflux pump gene norA and mecA gene in SCCmec gene cassettes of S. aureus. The results show that sertraline can regulate the multi-drug resistance of S. aureus by inhibiting the expression of resistance genes such as norA and mecA, and reverse the resistance of S. aureus to various antibiotics when it is combined with antibiotics. © 2019, Editorial Department, Journal of South China University of Technology. All right reserved.
引用
收藏
页码:64 / 70
页数:6
相关论文
共 32 条
  • [1] Lowy F.D., Staphylococcus aureus infections, New England Journal of Medicine, 339, 27, pp. 2026-2027, (1998)
  • [2] Kim H.K., Thammavongsa V., Schneewind O., Et al., Recurrent infections and immune evasion strategies of Staphylococcus aureus, Current Opinion in Microbiology, 15, 1, pp. 92-99, (2012)
  • [3] Kennedy A.D., Otto M., Braughton K.R., Et al., Epidemic community associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification, Proceedings of the National Academy of Sciences, 105, 4, pp. 1327-1332, (2008)
  • [4] Moran G.J., Krishnadasan A., Gorwitz R.J., Et al., Methicillin-resistant S. aureus infections among patients in the emergency department, New England Journal of Medicine, 355, 7, pp. 666-674, (2006)
  • [5] Sievert D.M., Rudrik J.T., Patel J.B., Et al., Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006, Clinical Infectious Diseases, 46, 5, pp. 668-674, (2008)
  • [6] Sieradzki K., Roberts R.B., Haber S.W., Et al., The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection, New England Journal of Medicine, 340, 7, pp. 517-523, (1999)
  • [7] Hiramatsu K., Hanaki H., Ino T., Et al., Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility, Journal of Antimicrobial Chemotherapy, 40, 1, pp. 135-136, (1997)
  • [8] Zhang Y.-Z., Li C., Yang L., Et al., The basic research of skullcap extract for Staphylococcus aureus in and out of the body, Science Technology and Engineering, 14, 21, pp. 191-194, (2014)
  • [9] Jiang P., Ma H.-J., Dai S.-J., Et al., Comparison of bacteriostasis of the radix sophorae flavescentis and antibiotics on the Staphylococcus aureus after the combination therapyin vitro, Journal of Yichun University, 40, 9, (2018)
  • [10] Chen F., Di H., Wang Y., Et al., Small-molecule targeting of a diapophytoene desaturase inhibits S. Aureus virulence, Nature Chemical Biology, 12, 3, pp. 174-179, (2016)